Press Releases

Clinical Ink Acquires Digital Artefacts

Global clinical trial data and technology company Clinical Ink has announced its acquisition of Digital Artefacts, a digital technology company that specializes in data capture for complex cognitive, behavioral, and physiological research. “Data derived from Digital Artefacts can now increase the richness of our partners’ study data through the convergence of passive and active digital assessments,” said Clinical Ink CEO Ed Seguine. “Their wearables and sensors acumen provides instrumented data collection that complements our existing products and solutions.” The combination of the two companies provides other benefits...

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi

Digital Biomarker company Koneksa announced an extension to its collaboration with Sanofi in central nervous system clinical trials. Sanofi is one of the world’s top biopharmaceutical companies, and Koneksa CEO Chris Benko expressed enthusiasm for the extension: “We’re proud that our long-term partnership has enabled Sanofi’s deployment of digital measures across multiple therapeutic areas and modalities.” He also noted continued collaboration with Sanofi will open an opportunity to study new treatment options for neurological diseases like multiple sclerosis. Specifically, Koneksa’s work with Safoni will benefit research...

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Aetion announced that it is expanding its relationship with the U.S. Food and Drug Administration to use real-world evidence to study COVID-19 interventions and advance regulatory science and innovation. The FDA and Aetion will use the Aetion Evidence Platform, validated software that enables efficient, transparent, and reliable RWE research, to develop a framework and system of studies for the rapid assessment of COVID-19 inpatient medical products. The project is designed to demonstrate how using a platform-based approach furthers regulatory learnings on the use of RWE to...

Carlyle and Leading Healthcare-Focused Venture Finds Announce Strategic Growth Investment of up to $430 Million in Saama

Saama Technologies announced that funds led by global investment firm Carlyle have made a strategic growth investment and will acquire a majority stake in the company. A broad co-investor group with several healthcare-focused venture funds including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, and Population Health Partners, will be investing alongside Carlyle. The partnership will allow Saama to accelerate its strategic initiatives including expanding its go-to-market capabilities and further investing in AI research and development. Saama’s intelligent Life Science...

Trinity Health Invests in Xealth to Accelerate Digital Health

Xealth has announced that Trinity Health, one of the nation’s largest Catholic healthcare systems, has invested in the company, bringing Xealth's total Series B funding to $25 million. This support demonstrates continued provider consensus in adopting digital health in a way that best engages both clinicians and patients. Digital therapeutics, mobile apps, and remote patient monitoring help fill a necessary role in extending care options for patients. Trinity Health is one of 15 healthcare systems that have funded Xealth; other investors include Advocate Aurora Enterprises, Banner...

Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector

Autolomous, a developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of digital enterprise platforms for cell and gene therapy supply chains, have announced a non-exclusive, collaborative partnership. The collaboration will integrate Autolomous’ critical manufacturing management systems with Vineti’s Personalized Therapy Management (PTM) platform. This will allow both parties to create a seamless end-to-end cell and gene therapy (CGT) delivery pathway, including critical inbound and outbound manufacturing value processes, which will result in an increase in the visibility and dynamic...

Körber and Vineti Announce Partnership to Provide improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies

Körber, a manufacturing execution systems supplier for pharma and biotech, has partnered with Vineti to integrate Körber’s Werum PAS-X-MES with Vineti’s Personalized Therapy Management (PTM) platform. The partnership will empower biopharma customers with an integrated PAS-X-MES and supply chain data management solution to bring life-saving cell and gene-based therapies to patients in need. Advanced therapies like cell and gene therapies and personalized vaccines require advanced software infrastructure across the entire production process. The advanced therapy industry requires digital visibility, automation, and real-time feedback in its technology,...

Lightship Raises $40 Million to Bring Clinical Trials to Every Patient in Need

Lightship, a virtual-first provider of clinical trials, today announced that it has raised $40 million to create access to clinical research for all patients, and improve diversity among patient groups taking part in clinical trials around the world. The funding round was led by Define Ventures and Brook Byers, with participation from Khosla Ventures, McKesson Ventures, and Marc Benioff’s TIME Ventures. These new funds will be used to help drive the firm’s expansion, including internationally, with a new office opening in the fall in London, United...

Augmedix Announces Partnership with Google Cloud to Harness Automated Speech Recognition Technology

Augmedix, a provider of virtual medical documentation and live clinical support, has partnered with Google Cloud to optimize and integrate automated speech recognition (ASR) technology for use in real-world clinical settings. ASR technology is a critical component in the Augmedix technology stack, and Augmedix is now integrating Google Cloud Speech-to-Text into its Notebuilder technology platform, which provides natural language processing (NLP) to produce a final clinical note. The combined ASR and NLP technology enhances the efficiency and quality of Augmedix’s medical documentation from ambient conversation while meeting...

AllStripes Announces Key Leadership Hires as Expansion and Growth Accelerate

AllStripes, a healthcare technology company dedicated to unlocking new treatments for people affected by rare diseases, has hired Sherwin Chen as chief legal officer and Joe Walsh as vice president and head of commercial. Chen is an experienced counsel specializing in advising high-growth digital health, biotech, and healthcare companies. Prior to this role, he was general counsel at Color Health, a population health company specializing in genetic testing and analysis, and before that he led legal teams at Roche and other leading life sciences companies. Walsh has...